Prevalent and Incident Use of SGLT2 Inhibitors

Project Title Prevalent and Incident Use of SGLT2 Inhibitors
Date Posted
Thursday, February 1, 2018
Project ID
to16_cap_str_wp031-032
Status
In progress
Deliverables
Mini-Sentinel Summary Table Report: Prevalent Use of SGLT2 Inhibitors
Description

These reports examine the prevalent and incident use of six sodium-glucose cotransporter 2 (SGLT2) inhibitors in the Mini-Sentinel Distributed Database (MSDD). These results were generated using the Mini-Sentinel Distributed Query Tool. Queries were run against the Dispensing Summary Table and distributed on May 18, 2015 to 14 Data Partners; this report includes information from 14 Data Partners.

Medical Product
canagliflozin
canagliflozin/metformin HCl
dapagliflozin propanediol
dapagliflozin/metformin HCl
empagliflozin
empagliflozin/linagliptin
Time Period
2013 - 2015
Assessment Type
Exploratory Analyses
Study Type
Summary Table
Data Sources
Mini-Sentinel Distributed Database (MSDD)
FDA Center
CDER
Scroll to Top